Evidence map›Paper›PMID 28936800›Full record

ArticleJournal of natural medicines2018

Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway.

Dongmei Yang, Li Li, Shanjun Qian, Lixin Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dongmei YangDepartment of Pharmacy, Anhui Medical College, No. 632, Furong Road, Economic and Technological Development Zone, Hefei, 230601, Anhui, People's Republic of China.ORCID http://orcid.org/0000-0002-3394-3545
Li LiDepartment of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, People's Republic of China.
Shanjun QianDepartment of Pharmacy, Anhui Medical College, No. 632, Furong Road, Economic and Technological Development Zone, Hefei, 230601, Anhui, People's Republic of China.
Lixin LiuDepartment of Pharmacy, Anhui Medical College, No. 632, Furong Road, Economic and Technological Development Zone, Hefei, 230601, Anhui, People's Republic of China. lixinliu522@163.com.ORCID http://orcid.org/0000-0002-0597-7828
Anhui Medical University · CN

Funding

Natural Sciences Research Key Project of Education Department of Anhui KJ2016A381
6 · The paper itself

Abstract

Liver fibrosis is considered to be a result of chronic liver pathological changes, and hepatic stellate cells (HSCs) play an important role during this process. Evodiamine, an indole alkaloid derived from Evodia rutaecarpa, exhibits pharmacological activities. This study focused on the effects of evodiamine on carbon tetrachloride (CCl

Indexed as

AnimalsDisease Models, AnimalLiver CirrhosisMaleQuinazolinesRatsRats, WistarSmad ProteinsTransforming Growth Factor beta1evodiamineQuinazolinesSmad ProteinsTransforming Growth Factor beta1EvodiamineHSCsLiver fibrosisp-Smad 2/3TGF‐β1α-SMA

Identifiers

PMID28936800
OpenAlexW2759154444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.